David Hardick
Impact in
- Pharmacology top 2%
- Plant-based Medicinal Research
- Cholinesterase and Neurodegenerative Diseases
- Toxicology top 5%
Papers in
-
- Nicotinic Acetylcholine Receptors Study 5
- Cancer therapeutics and mechanisms 2
-
- Plant-based Medicinal Research 8
- Alkaloids: synthesis and pharmacology 3
- Microbial Natural Products and Biosynthesis 2
- Co-authors
- Barry V. L. Potter (10 shared papers)Ian S. Blagbrough (10 shared papers)Susan Wonnacott (9 shared papers)Adrian J. Wolstenholme (3 shared papers)Andrew R. Davies (3 shared papers)D. W. Hutchinson (3 shared papers)Elizabeth M. H. Wellington (2 shared papers)Gary R. Cooper (2 shared papers)
- Journals
- Tetrahedron Letters (4 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)The Journal of Antibiotics (1 paper)Journal of the American Chemical Society (1 paper)
- Partner nations
- United KingdomNew Zealand
In The Last Decade
David Hardick
19 papers receiving 791 citations
Peers
Comparison fields: 5 of 72
- Pharmacology 197
- Toxicology 57
- Organic Chemistry 331
- Pharmacology 157
- Molecular Biology 546
Countries citing papers authored by David Hardick
This map shows the geographic impact of David Hardick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hardick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hardick more than expected).
Fields of papers citing papers by David Hardick
This network shows the impact of papers produced by David Hardick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hardick. The network helps show where David Hardick may publish in the future.
Co-authors
The 25 scholars most cited alongside David Hardick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 222 | |
| 2 | 2002 | 116 | |
| 3 | 1996 | 73 | |
| 4 | 1992 | 69 | |
| 5 | 2002 | 49 | |
| 6 | 1995 | 32 | |
| 7 | 1994 | 30 | |
| 8 | 1994 | 29 | |
| 9 | 2011 | 26 | |
| 10 | 1996 | 26 | |
| 11 | 1994 | 25 | |
| 12 | 1991 | 24 | |
| 13 | 2001 | 21 | |
| 14 | 2007 | 21 | |
| 15 | 1997 | 17 | |
| 16 | 1994 | 15 | |
| 17 | 2001 | 14 | |
| 18 | 2007 | 9 | |
| 19 | 1994 | 5 |
About David Hardick
David Hardick is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Pharmacology and Pharmaceutical Science, having authored 19 papers that have together received 823 indexed citations. Recurring topics across this work include Plant-based Medicinal Research (8 papers), Nicotinic Acetylcholine Receptors Study (5 papers), Carbohydrate Chemistry and Synthesis (3 papers), Alkaloids: synthesis and pharmacology (3 papers), Chemical Reactions and Isotopes (2 papers), Cancer therapeutics and mechanisms (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Pharmacology (197 citations), Toxicology (57 citations), Organic Chemistry (331 citations), Pharmacology (157 citations) and Molecular Biology (546 citations). David Hardick has collaborated with scholars based in United Kingdom and New Zealand. Frequent co-authors include Barry V. L. Potter, Ian S. Blagbrough, Susan Wonnacott, Adrian J. Wolstenholme, Andrew R. Davies, D. W. Hutchinson, Elizabeth M. H. Wellington, Gary R. Cooper, Prakash Mistry and Warren Miller. Their work appears in journals such as Tetrahedron Letters, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, The Journal of Antibiotics and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.